ISBT 2002 Abstracts

Adobe Acrobat required for viewing Abstracts. Download it free here.

To save an abstract, right click, and choose "Save Target As".

• Comparative Study of Three NAT Assays: PROCLEIX^®, Extractor/Ampliscreen, Multiprep/Ampliscreen
• HCV-NAT Testing of Singapore Blood Donors
• Hepatitis C Antibody Profiles for NAT Yield Donors
• Cost Effectiveness (ce) Analysis of Screening Donated Blood with Nucleic Acid Testing (NAT) for Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human Immunodeficiency Virus (HIV)
• Identification and Characterization of Parvovirus B19 for Chilean Clinical Specimens
• Performance Characteristics of PCR Based Parvovirus B19 Nucleic Acid Testing Confirmatory Assay for the PROCLEIX^® Parvovirus B19/Hepatitis A Virus Assay
• First Detection in France of an HIV-1 Confirmed-Positive Blood Donor by NAT
• Development of Transcription-Mediated Assay for Quantitation of Hepatitis B Virus
• Effect of Donor Mini-Pool Size on Closure of the Hepatitis B Virus (HBV) Detection Window: A Comparison of Triplex Transcription-Mediated Amplificiation (TMA) to Surface Antigen Detection
• A Fully Automated, High Throughput System for Simultaneous Screening of HIV-1, HCV and HBV in Blood Donations
• The NAT Laboratory of Brescia Dmte: From Drawing to Report
• Utility of External Run Control for NAT Screening
• Validation of PROCLEIX^® HIV-1/HCV Assay on 8-Sample Minipools
• Performance of the PROCLEIX^® HIV-1/HCV Assay was not Adversely Affected by the Sudden Increase in Testing Volume After the N.Y. World Trade Center Disaster
• Specificity of the PROCLEIX^® HIV-1/HCV Assay for Routing Blood Screening of Individual Donor Samples
• Performance Characteristics of Hepatitis B Virus DNA Confirmatory Assay for PROCLEIX^® Triplex Assay
• Performance of the PROCLEIX^® HIV-1/HCV Assay on the TIGRIS^® Automated Instrument Platform
• Sensitivity and Specificity of a TMA-based Triplex Assay for Simultaneous Screening of HIV-1, HCV And HBV in Blood Donations
• Simultaneous Detection of Parvovirus B19 and Hepatitis A Virus (HAV) in Human Plasma Using a Transcription-Mediated Amplification (TMA) Assay
• Screening by NAT Assay of Blood Components from Brescia Dmte
• Interference of Maize Starch, a Dust Used as a Lubricant of Sanitary Gloves, on Analytical Results of NAT Test
• NAT Screening: A Study on Stability of HCV and HIV-1 Nucleic Acids
• Routine Screening of Blood Units with NAT Test. Experience of the Supraregional Transfusion Service
• HIV Incidence among Blood Donors in Republic of South Africa: Donor Risk Category Correlates and Implications for Donor Screening Policies